Abstract
Epidemiological evidence points to an increased risk of breast cancer in ataxia telangiectasia (AT) heterozygote women. Previous attempts to screen early onset or familial breast cancer patients failed to confirm an association. The issue of AT and late onset sporadic breast cancer remained unresolved. We screened 47 women who developed later onset, sporadic breast cancer for ataxia telangiectasia mutated (ATM) mutations. No mutations were found.
MeSH terms
-
Adult
-
Age of Onset
-
Aged
-
Ataxia Telangiectasia / genetics
-
Ataxia Telangiectasia Mutated Proteins
-
Breast Neoplasms / blood
-
Breast Neoplasms / genetics*
-
Cell Cycle Proteins
-
DNA-Binding Proteins
-
Female
-
Genetic Carrier Screening*
-
Humans
-
Middle Aged
-
Mutation*
-
Polymerase Chain Reaction
-
Protein Serine-Threonine Kinases*
-
Proteins / genetics*
-
RNA / blood
-
Sensitivity and Specificity
-
Tumor Suppressor Proteins
Substances
-
Cell Cycle Proteins
-
DNA-Binding Proteins
-
Proteins
-
Tumor Suppressor Proteins
-
RNA
-
ATM protein, human
-
Ataxia Telangiectasia Mutated Proteins
-
Protein Serine-Threonine Kinases